# A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study

> **NCT06801379** · EARLY_PHASE1 · RECRUITING · sponsor: **Woolcock Institute of Medical Research** · enrollment: 5 (estimated)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** Inhaled Melatonin (100 μg)
- **DRUG:** Oral Melatonin (4 mg)

## Key facts

- **NCT ID:** NCT06801379
- **Lead sponsor:** Woolcock Institute of Medical Research
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-05-01
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06801379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06801379, "A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06801379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*